Shareholder Alert: Ademi LLP investigates whether LHC Group, Inc. has obtained a Fair Price in its transaction with UnitedHealth Group's Optum

MILWAUKEE

,

March 29, 2022

/PRNewswire/ -- Ademi LLP is investigating LHC Group (NASDAQ:LHCG) for possible breaches of fiduciary duty and other violations of law in its transaction with UnitedHealth Group's Optum. 

Click here to learn how to join the action: https://www.ademilaw.com/case/lhc-group-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Ademi LLP alleges LHC Group's financial outlook and prospects are excellent and yet LHC Group shareholders will receive only $170 per share. The transaction agreement unreasonably limits competing bids for LHC Group by prohibiting solicitation of further bids, and imposing a significant penalty if LHC Group accepts a superior bid. LHC Group insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of LHC Group's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for LHC Group.

If you own LHC Group common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/lhc-group-inc.                 

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP                                                          
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-lhc-group-inc-has-obtained-a-fair-price-in-its-transaction-with-unitedhealth-groups-optum-301512741.html

SOURCE Ademi LLP